Two Sigma Securities, LLC Sonoma Pharmaceuticals, Inc. Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.14 - $0.26 $259 - $481	1,852 Added 13.75%	15,325 $3,000
Q1 2024 May 15, 2024	BUY	$0.13 - $0.23 $1,751 - $3,098	13,473 New	13,473 $2,000
Q3 2023 Nov 14, 2023	SELL	$0.76 - $1.16 $10,275 - $15,683	-13,520 Reduced 25.98%	38,522 $29,000
Q2 2023 Aug 14, 2023	BUY	$0.92 - $1.4 $47,878 - $72,858	52,042 New	52,042 $55,000
Q2 2022 Aug 15, 2022	SELL	$2.65 - $4.12 $101,020 - $157,058	-38,121 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.65 - $4.84 $101,020 - $184,505	38,121 New	38,121 $153,000

2.27K

Ticker SNOA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,100,940
Market Cap $8.84M
Description
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.